Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-09-24
1987-01-20
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514413, 546200, 548453, 548532, 548533, A61K 31445, C07D48704
Patent
active
046380060
ABSTRACT:
A unique series of N,N-dialkylaminoalkyl-hexahydro-5-oxo-1H-pyrrolizine-3-carboxamides are disclosed. These compounds are useful as agents for the reversal of amnesia. Intermediates for preparing the compounds, pharmaceutical compositions containing them, and methods for using the pharmaceutical compositions for treating senility and for the reversal of amnesia are described.
REFERENCES:
patent: 4145347 (1979-03-01), L'Italien et al.
patent: 4563469 (1986-01-01), Butler et al.
Davies, W. et al., Tetrahedron, 1962, 18 405-12.
Anderson Elizabeth M.
Schwartz Richard A.
Warner & Lambert Company
LandOfFree
Amnesia reversal with N,N-dialkylaminoalkyl-hexahydro-5-oxo 1H-p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amnesia reversal with N,N-dialkylaminoalkyl-hexahydro-5-oxo 1H-p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amnesia reversal with N,N-dialkylaminoalkyl-hexahydro-5-oxo 1H-p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2134956